[Azuaga AB, Celis R, Frade-Sosa B, Sarmiento-Monroy JC, Ruiz-Esquide V, Gómez-Puerta JA, Sanmartí R, Ramírez J] Rheumatology Department, Hospital Clinic of Barcelona, Barcelona, Spain. [Cuervo A] Rheumatology Department, Hospital General de Granollers, Granollers, Spain
Hospital General de Granollers
2024-05-23T10:27:13Z
2024-05-23T10:27:13Z
2024-01-10
Psoriatic arthritis; Rheumatoid arthritis; Synovial tissue
Artritis psoriásica; Artritis reumatoide; Tejido sinovial
Artritis psoriàsica; Artritis reumatoide; Teixit sinovial
Background: Inflammatory arthritis encompasses a group of immune-mediated diseases characterized by chronic joint inflammation. Despite having pathogenic mechanisms in common, the prognosis of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and undifferentiated arthritis (UA) could be different regarding progression to chronic, to erosive, or to self-limited disease. Our aim was to evaluate the potential association of synovial tissue (ST) inflammatory cell infiltrate, the presence of ectopic lymphoid neogenesis (LN +) structures, and poor prognosis factors (PPF) in patients with RA, PsA, and UA. Methods: We conducted a retrospective study including patients with active arthritis (RA, PsA, UA) who had ST obtained by rheumatological arthroscopy or ultrasound-guided biopsy. Clinical, demographic, and immunohistochemical data of the synovium was evaluated. Patients with biological therapy at the time of synovial biopsy were excluded. PPF in patients with RA and UA were defined by the presence of anti-cyclic citrullinated peptide antibodies and/or rheumatoid factor, development of bone erosions, or requirement of biological therapy during the follow-up. PPF in patients with PsA were defined as the presence of high levels of acute-phase reactants (ESR/CRP), dactylitis or nail involvement at the time of biopsy, development of bone erosion, or requirement of biological therapy during the follow-up. Results: A total of 88 patients were included: 26 RA, 33 PsA, and 29 UA. All patients were followed up for 5 years after the biopsy. Fourteen (53.84%) RA patients had PPF, and 17 (65.38%) had LN + . LN + was associated with PPF (p 0.038) and biologic therapy initiation (p 0.018). A total of 14 (43.75%) PsA patients had PPF. CD15 infiltrate (410.68 [SD 477.63] cells/mm2) was associated with PPF (p 0.008) in PsA patients. Sixteen (55.17%) patients with UA had PPF, and 13 (44.82%) had LN + . In this group, synovial CD68 + macrophages cells density was negatively correlated with DAS28-CRP (r = - 0.346, p 0.042). Conclusions: The presence of LN + and higher CD15 + polymorphonuclear cells infiltrate was associated with PPF in RA and PsA, respectively. No associations were found for UA. These findings suggest a great heterogeneity of the ST features and its pathogenic implications in the subtypes of inflammatory arthritis.
Article
Versió publicada
Anglès
Artritis psoriàsica; Artritis reumatoide; Reumatisme; DISEASES::Musculoskeletal Diseases::Musculoskeletal Diseases::Joint Diseases::Arthritis::Musculoskeletal Diseases::Joint Diseases::Arthritis::Arthritis, Psoriatic; DISEASES::Musculoskeletal Diseases::Musculoskeletal Diseases::Rheumatic Diseases::Arthritis, Rheumatoid; ANATOMY::Musculoskeletal System::Skeleton::Joints::Joint Capsule::Synovial Membrane; ENFERMEDADES::enfermedades musculoesqueléticas::enfermedades musculoesqueléticas::artropatías::artritis::enfermedades musculoesqueléticas::artropatías::artritis::artritis psoriásica; ENFERMEDADES::enfermedades musculoesqueléticas::artropatías::artritis::artritis reumatoide; ANATOMÍA::sistema musculoesquelético::esqueleto::articulaciones::cápsula articular::membrana sinovial
BMC
Arthritis Research & Therapy;26(1)
https://doi.org/10.1186/s13075-023-03255-9
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HG [171]